Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

The same gene mutation can cause different symptoms in family members.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

The assay effectively detects hormonal activity of certain chemicals.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Androgens improve memory in adolescent male rats by acting on brain receptors.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Nuclear AR levels give better insight into hormone effects in skin conditions.